SEOUL, South Korea, Nov. 19, 2024 /PRNewswire/ -- Statistics Korea is currently conducting the 2024 Address Canvassing, in preparation for the centenary population census next year. This Survey lasts for 20 days from November 8 to November 27 this year.
As a vital preparatory step for next year's Population and Housing Census, as well as the Agriculture, Forestry, and Fisheries Census, the Survey aims to deliver a complete and accurate address lists and spatial database for enumeration and determine the type and address characteristics for each living quarter. This basic information will inform the creation of sample frame and enumeration for the Censuses' field operation next year.
A few notable changes are adopted in this year's Survey. Specifically, this operation this year implements both in-office and in-field methods to update information, in other words, information on the apartment-type dwellings* is being gathered through administrative and spatial data instead of field surveys. Other data are collected through field surveys using an advanced tablet-based electronic survey system that allows enumerators to enter and verify collected data in real-time, lowering survey burdens while enhancing the accuracy and speed of data collection.
With the launch of address canvassing, Statistics Korea is moving forward with full-scale preparation of the 2025 Population and Housing Census. The core framework of the upcoming Census is designed to tackle increasingly challenging survey conditions in the post-COVID-19 environment, adapt to rapid social changes, and reduce the response burden on citizens. Under this framework, Statistics Korea aims to encourage active participation and reliable responses from all residents in Korea, with the ultimate goal of producing high-quality census data.
Specifically, the 2025 Census will feature the use of user-friendly mobile questionnaires and an extensive offering of foreign language questionnaires (in 20 languages) to promote participation of foreign residents and internet participation.
* In addition to the 10 existing languages (English, Chinese, Vietnamese, Russian, Indonesian, Thai, Mongolian, Japanese, Cambodian, and Nepali), 10 more languages will be available, including Uzbek, Kazakh, Burmese, Sinhala (Sri Lanka), Bengali (Bangladesh), and Urdu (Pakistan).
The Census will also leverage Artificial Intelligence (AI) technology to classify industry and occupation categories and provide 24/7 support through Census help desks, enhancing data processing accuracy and enabling prompt responses to participant inquiries. To reduce the burden on respondents, certain questionnaire items will be replaced with information from administrative data. Additionally, Statistics Korea is considering the inclusion of new survey items in the Census, such as marriage intention, family planning, caregiving, and Korean language proficiency, to better reflect social diversity and capture trends related to low fertility, aging, and the multicultural aspect of the society.
Korea employs a combined census approach that integrates register-based complete enumeration with sample-based field surveys. This highlights Korea's notable advancements in statistical work, including the statistical use of administrative data, field survey techniques, and statistical systems development, that is built on robust technical and administrative expertise across all aspects of national statistics - from data collection and processing to production and distribution of data.
Korea's advanced census methodologies have been shared with many countries across Southeast Asia, South America, and Africa, including Vietnam, Colombia, Bolivia, Indonesia, Tanzania, and Mongolia, with plans to transfer K-Census expertise to Uzbekistan next year.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Statistics Korea, Preparing for the Centenary Population Census with the Launch of the 2024 Address Canvassing
BANGKOK, Nov. 19, 2024 /PRNewswire/ -- Medeze Group Public Company Limited (Medeze Group), Thailand's foremost hematopoietic (HSC), mesenchymal stem cell (MSC) bank and leader in regenerative healthcare, has received the esteemed Industry Champions of the Year Award at the 2024 Asia Corporate Excellence & Sustainability (ACES) Awards, organised by MORS Group.
Since its establishment in 2010 as Bangkok Stem Cell, Medeze Group has expanded from a focused stem cell storage provider to a transformative leader in regenerative healthcare. With a strong focus on HSC and MSC banking, the company has integrated cutting-edge technologies and rigorous quality standards into its operations to deliver advanced health solutions across Southeast Asia.
Today, Medeze Group operates Southeast Asia's largest, state-of-the-art stem cell laboratories, equipped with NEBB-certified Class 10 Cleanrooms and adhering to American Association of Blood Banks (AABB) standards. Its commitment to operational excellence has driven the development of innovative cells banking, positioning the company at the forefront of longevity-focused health solutions. Notably, Medeze introduced Thailand's first MSC storage for umbilical cord tissue and the world's pioneering adipose tissue storage service for future versatile stem cell solutions that play vital roles in treating conditions such as heart disease, diabetes, and neurodegenerative disorders. These therapies also support anti-aging and preventive healthcare, making Medeze a trailblazer in the science of longevity.
A key advancement for Medeze is its development of a Natural Killer (NK) cell immunotherapy programme, designed to support the body's natural immune defences against pathogens and cancer cells. NK cells are vital to immune health, and Medeze's lab- NK cell activity test aims to bolster immune status. This innovative approach underscores Medeze's commitment to addressing the growing global demand for health solutions that combat chronic illnesses and cancer.
Medeze's reach extends through a robust network of partnerships across nine countries in the Asia-Pacific region, including Singapore, Vietnam, Taiwan, and Indonesia. With significant collaborations with over 200 hospitals and clinics in Thailand, including Bangkok Hospital and Bumrungrad Hospital, This extensive presence highlights Medeze's accessibility and leadership, providing thousands of individuals with innovative options for preventive and longevity-focused healthcare.
Beyond its healthcare innovations, Medeze is dedicated to public education and community health improvement. In 2015, the company founded the Bangkok Stem Cell Foundation to advance stem cell therapy awareness and accessibility, supporting public health through education, research, and community outreach. This philanthropic initiative aligns with Medeze's purpose-driven mission, contributing to the advancement of regenerative medicine across Thailand.
Receiving the Industry Champions of the Year Award marks an important milestone for Medeze Group, celebrating its commitment to scientific excellence, quality, and innovation in regenerative healthcare. Medeze's focus on delivering accessible, high-quality healthcare solutions resonates with the values of the ACES Awards, showing its dedication to integrity, transformative impact, and long-term value. Shanggari B, the President of ACES Awards, underscores the exceptional contributions of Medeze Group in the field of regenerative medicine. "When it comes to regenerative medicine and a visionary approach to health and longevity, no one does it better than Medeze Group. Medeze has set an inspiring benchmark in stem cell banking and immune analysis, leading the way in Southeast Asia and beyond," she states. As healthcare in Asia-Pacific evolves, Medeze Group is well-positioned, offering a gold standard of healthcare excellence that is as ambitious as it is impactful.
About Medeze Group Public Company Limited
Founded in 2010 and headquartered in Thailand, Medeze Group is a leader in stem cell banking, dedicated to advancing preventive and longevity-focused healthcare across Southeast Asia and beyond. Medeze's network spans nine countries, supported by collaborations with over 200 hospitals and clinics in Thailand. With cutting-edge solutions for regenerative medicine and health optimisation, Medeze Group is committed to setting new standards in longevity science. For more information, please visit https://www.medezegroup.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Medeze Group Honoured with Industry Champions of the Year Award for Advancements in Longevity Science and Regenerative Healthcare
